Duk-Sang Kim
Director/Board Member at EUBIOLOGICS CO., LTD.
Net worth: 14 M $ as of 29/04/2024
Profile
Duk-Sang Kim is currently the Chief Executive Officer at Sartorius Korea Biotech Co., Ltd.
and a Non-Executive Director at EuBiologics Co., Ltd.
He previously served as an Independent Director at Plumbline Life Sciences, Inc. Kim received his graduate and doctorate degrees from Korea University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
EUBIOLOGICS CO., LTD.
3.88% | 05/10/2022 | 1,416,060 ( 3.88% ) | 14 M $ | 29/04/2024 |
Duk-Sang Kim active positions
Companies | Position | Start |
---|---|---|
EUBIOLOGICS CO., LTD. | Director/Board Member | - |
Sartorius Korea Biotech Co., Ltd.
Sartorius Korea Biotech Co., Ltd. Engineering & ConstructionIndustrial Services Part of Sartorius AG, Sartorius Korea Biotech Co., Ltd. is a South Korean company that provides engineering services. The company is based in Seongnam, South Korea. The company was founded in 2005. Duk-Sang Kim has been the CEO of the company since 2005. | Chief Executive Officer | 31/01/2005 |
Former positions of Duk-Sang Kim
Companies | Position | End |
---|---|---|
PLUMBLINE LIFE SCIENCES, INC. | Director/Board Member | - |
Training of Duk-Sang Kim
Korea University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
EUBIOLOGICS CO., LTD. | Health Technology |
PLUMBLINE LIFE SCIENCES, INC. | Health Technology |
Private companies | 1 |
---|---|
Sartorius Korea Biotech Co., Ltd.
Sartorius Korea Biotech Co., Ltd. Engineering & ConstructionIndustrial Services Part of Sartorius AG, Sartorius Korea Biotech Co., Ltd. is a South Korean company that provides engineering services. The company is based in Seongnam, South Korea. The company was founded in 2005. Duk-Sang Kim has been the CEO of the company since 2005. | Industrial Services |
- Stock Market
- Insiders
- Duk-Sang Kim